Industry News

Submission does not meet editorial criteria for functional foods, nutraceuticals, or ingredient science coverage.

The Toronto-based diagnostics firm's repeat recognition signals competitive talent dynamics in Canada's health sciences…

Submission does not meet Functional News editorial criteria. No ingredient, clinical data, formulation, or regulatory a…

Submitted content does not meet Functional News editorial scope. No ingredient, mechanism, clinical data, or finished f…

Functional News covers ingredients, clinical evidence, regulatory developments, and market trends in functional foods a…

Functional News covers dietary supplements, functional foods, and nutraceutical ingredients. Pharmaceutical oncology tr…

Revumenib is an FDA-approved menin inhibitor for acute leukemia, not a dietary ingredient, functional food, or nutraceu…

Functional News covers ingredients, clinical evidence, formulation, and regulation in the functional foods and nutraceu…

The late-stage biopharmaceutical's shareholder vote arrives amid growing industry interest in bradykinin-pathway modula…

Functional News covers ingredient science, clinical evidence, regulatory developments, and operator strategy in the fun…

Functional News covers ingredient science, clinical evidence, regulatory affairs, and operator strategy for the functio…

Functional News covers ingredients, clinical evidence, formulation, and regulation — this submission falls outside all …

Stay ahead of the industry